Stock 688117 CHENGDU SHENGNUO BIOTEC CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company ChengDu ShengNuo Biotec Co.,Ltd.

Equities

688117

CNE1000051M8

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 30/05/2024 BST 		5-day change 1st Jan Change
25.13 CNY +1.82% Intraday chart for ChengDu ShengNuo Biotec Co.,Ltd. -1.45% -10.89%
05-07 Sheng Nuo Biotec's Unit Gets Nod to Produce Posaconazole Injection MT
04-22 ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Cheng Du Sheng Nuo Biotec Co Ltd is a China-based company mainly engaged in the research and development of peptide active pharmaceutical ingredients (APIs) and preparation products. The Company's products target areas including immunology, digestive tract, antivirus, gynecology, diabetes, cardio-cerebrovascular, rare diseases, orthopedics and other fields. The Company is also engaged in customized peptide production services for customers, customized production services for peptide APIs and preparations, and technology transfer services for peptide drug production. The Company also provides small-molecule chemical drug Levosimendan preparations on behalf of processing, Levosimendan bulk drug production and export sales business.

Number of employees: 1,128

Sales per Business

CNY in Million2022Weight2023Weight Delta
Preparation
40.6 %
135 34.0 % 177 40.6 % +31.22%
Active Pharmaceutical Ingredients
27.4 %
141 35.5 % 119 27.4 % -15.07%
Pharmaceutical Research
21.2 %
69 17.3 % 92 21.2 % +34.57%
Entrusted Processing
7.3 %
30 7.6 % 32 7.3 % +5.13%
Customized Production
2.5 %
13 3.2 % 11 2.5 % -13.15%
Other
0.9 %
9 2.2 % 4 0.9 % -58.17%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
80.2 %
282 72.8 % 346 80.2 % +22.82%
Overseas
19.8 %
105 27.2 % 85 19.8 % -18.89%

Managers

Managers TitleAgeSince
Yong Jun Wen CEO
 Chief Executive Officer 58 22/07/01
Li Wu DFI
 Director of Finance/CFO 50 30/09/14
Jing Meng Zhang ADM
 Chief Administrative Officer 43 31/05/06
Xiao Hai Yu BRD
 Director/Board Member 36 31/03/15
Jin Shu Ren BRD
 Director/Board Member 54 31/01/11
Fa Sheng Wen BRD
 Director/Board Member 44 30/11/16
Xiao Li Wang BRD
 Director/Board Member 54 28/02/03
Lu Zhang IRC
 Investor Relations Contact 31 31/03/21
Zhong Gang Ma PRN
 Corporate Officer/Principal 42 26/12/16

Members of the board

Members of the board TitleAgeSince
Guo Qiong Tang BRD
 Director/Board Member 61 11/12/18
Yong Jun Wen CEO
 Chief Executive Officer 58 22/07/01
Xiao Li Wang BRD
 Director/Board Member 54 28/02/03
Fa Sheng Wen BRD
 Director/Board Member 44 30/11/16
Ya Fei Song BRD
 Director/Board Member 36 24/05/17
Jia Qin Liu BRD
 Director/Board Member 57 25/04/19
De Zhi Zeng CHM
 Chairman 45 30/11/16
Jing Meng Zhang ADM
 Chief Administrative Officer 43 31/05/06
Xiao Hai Yu BRD
 Director/Board Member 36 31/03/15
Li Wu DFI
 Director of Finance/CFO 50 30/09/14

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 112,000,000 56,280,161 ( 50.25 %) 0 50.25 %

Shareholders

NameEquities%Valuation
China Fund Management Co., Ltd.
5.814 %
3,850,000 5.814 % 15 M ¥
GF Fund Management Co., Ltd.
5.149 %
3,409,413 5.149 % 14 M ¥
Rongtong Fund Management Co., Ltd.
3.684 %
2,439,613 3.684 % 10 M ¥
Golden Trust Sinopac Fund Management Co., Ltd.
2.136 %
1,414,500 2.136 % 6 M ¥
China Southern Asset Management Co., Ltd.
1.687 %
1,117,209 1.687 % 4 M ¥
HuaAn Fund Management Co., Ltd.
1.668 %
1,104,585 1.668 % 4 M ¥
Everbright PGIM Fund Management Co. Ltd.
0.4647 %
307,698 0.4647 % 1 M ¥
Goldstate Capital Fund Management Co., Ltd.
0.3877 %
256,763 0.3877 % 1 M ¥
Harfor Fund Management Co., Ltd.
0.2416 %
160,000 0.2416 % 641 194 ¥
Great Wall Fund Management Co., Ltd.
0.1489 %
98,593 0.1489 % 395 108 ¥
NameEquities%Valuation
Roton Capital Management Co. Ltd.
4.600 %
1,540,000 4.600 % 6 M ¥

Company contact information

Cheng Du Sheng Nuo Biotec Co., Ltd.

No. 98, Da'an Road Dayi County

611330, Chengdu

+

http://www.snbiopharm.com
address ChengDu ShengNuo Biotec Co.,Ltd.(688117)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sales per region

Ratings for ChengDu ShengNuo Biotec Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
25.13 CNY
Average target price
38 CNY
Spread / Average Target
+51.21%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

1st Jan change Capi.
CHENGDU SHENGNUO BIOTEC CO.,LTD. Stock ChengDu ShengNuo Biotec Co.,Ltd.
-10.89% 389M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+15.91% 41.97B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+22.40% 22.34B
SANDOZ GROUP AG Stock Sandoz Group AG
+18.48% 15.25B
CIPLA LIMITED Stock Cipla Limited
+16.12% 14B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+45.12% 12.06B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-9.58% 6.8B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+14.18% 5.49B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 688117 Stock
  4. Company ChengDu ShengNuo Biotec Co.,Ltd.